United Kingdom Diabetes Market Report: 2019 - 2024
IMARC’s new report “United Kingdom Diabetes Market Report: 2019 - 2024” provides an analytical and statistical insight into the UK diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in UK. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the UK diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the UK diabetes market in any form.
What we have achieved in this report:
Comprehensive situation analysis of the UK diabetes epidemiology and its dynamics:
Focus of the Analysis:
Historical, current and future prevalence of diabetes in UK
Historical, current and future prevalence of type-1 and type-2 diabetes in UK
Historical, current and future prevalence of diabetes in the urban and rural regions in UK
Historical, current and future prevalence of diabetes among males and females in UK
Historical, current and future prevalence of diabetes among various age groups in UK
Historical, current and future diagnosis rates for diabetes in UK
Historical, current and future drug treatment rates for diabetes in UK
Comprehensive situation analysis of the UK Oral Antidiabetics market and its dynamics:
Focus of the Analysis:
Performance of the Oral Antidiabetics market in UK
Performance of key classes
Performance of key players
Market outlook
Comprehensive situation analysis of the UK Insulin market and its dynamics:
Focus of the Analysis:
Performance of the Insulin market in UK
Performance of key classes
Performance of key players
Market outlook
What we have achieved in this report:
Comprehensive situation analysis of the UK diabetes epidemiology and its dynamics:
Focus of the Analysis:
Historical, current and future prevalence of diabetes in UK
Historical, current and future prevalence of type-1 and type-2 diabetes in UK
Historical, current and future prevalence of diabetes in the urban and rural regions in UK
Historical, current and future prevalence of diabetes among males and females in UK
Historical, current and future prevalence of diabetes among various age groups in UK
Historical, current and future diagnosis rates for diabetes in UK
Historical, current and future drug treatment rates for diabetes in UK
Comprehensive situation analysis of the UK Oral Antidiabetics market and its dynamics:
Focus of the Analysis:
Performance of the Oral Antidiabetics market in UK
Performance of key classes
Performance of key players
Market outlook
Comprehensive situation analysis of the UK Insulin market and its dynamics:
Focus of the Analysis:
Performance of the Insulin market in UK
Performance of key classes
Performance of key players
Market outlook
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 DIABETES DISEASE OVERVIEW
5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Diabetes Complications
6 UK DIABETES EPIDEMIOLOGY
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group
7 UK DIABETES MARKET
7.1 Market Overview
7.2 Market Performance
7.3 Market Forecast
7.4 SWOT Analysis
7.4.1 Overview
7.4.2 Strengths
7.4.3 Weaknesses
7.4.4 Opportunities
7.4.5 Threats
7.5 Value Chain Analysis
7.6 Porter’s Five Forces Analysis
7.6.1 Overview
7.6.2 Bargaining Power of Buyers
7.6.3 Bargaining Power of Suppliers
7.6.4 Degree of Competition
7.6.5 Threat of New Entrants
7.6.6 Threat of Substitutes
7.7 Market Breakup by Segment
7.7.1 UK Oral Antidiabetics Market
7.7.1.1 Historical Market Trends
7.7.1.2 Market Breakup by Class
7.7.1.3 Market Shares of Key Players
7.7.1.4 Market Forecast
7.7.2 UK Insulin Market
7.7.2.1 Historical Market Trends
7.7.2.2 Market Breakup by Class
7.7.2.3 Market Shares of Key Players
7.7.2.4 Market Forecast
8 COMPETITIVE LANDSCAPE
8.1 Competitive Structure
8.2 Profiles of Key Players
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 DIABETES DISEASE OVERVIEW
5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Diabetes Complications
6 UK DIABETES EPIDEMIOLOGY
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group
7 UK DIABETES MARKET
7.1 Market Overview
7.2 Market Performance
7.3 Market Forecast
7.4 SWOT Analysis
7.4.1 Overview
7.4.2 Strengths
7.4.3 Weaknesses
7.4.4 Opportunities
7.4.5 Threats
7.5 Value Chain Analysis
7.6 Porter’s Five Forces Analysis
7.6.1 Overview
7.6.2 Bargaining Power of Buyers
7.6.3 Bargaining Power of Suppliers
7.6.4 Degree of Competition
7.6.5 Threat of New Entrants
7.6.6 Threat of Substitutes
7.7 Market Breakup by Segment
7.7.1 UK Oral Antidiabetics Market
7.7.1.1 Historical Market Trends
7.7.1.2 Market Breakup by Class
7.7.1.3 Market Shares of Key Players
7.7.1.4 Market Forecast
7.7.2 UK Insulin Market
7.7.2.1 Historical Market Trends
7.7.2.2 Market Breakup by Class
7.7.2.3 Market Shares of Key Players
7.7.2.4 Market Forecast
8 COMPETITIVE LANDSCAPE
8.1 Competitive Structure
8.2 Profiles of Key Players
LIST OF TABLES
Table 1: Diagnosis of Diabetes
Table 2: Global: Diabetes Population Breakup by Country (in 000’s), 2018 and 2024
Table 3: UK: Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 4: UK (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 5: UK (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 6: UK (Male & Female): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 7: UK: Total Prevalence & Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79, in 000), 2011, 2018 & 2024
Table 8: UK: Diabetes Drug Market: Competitive Structure
Table 9: UK: Diabetes Drug Market: Key Players
Table 1: Diagnosis of Diabetes
Table 2: Global: Diabetes Population Breakup by Country (in 000’s), 2018 and 2024
Table 3: UK: Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 4: UK (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 5: UK (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 6: UK (Male & Female): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
Table 7: UK: Total Prevalence & Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79, in 000), 2011, 2018 & 2024
Table 8: UK: Diabetes Drug Market: Competitive Structure
Table 9: UK: Diabetes Drug Market: Key Players
LIST OF FIGURES
Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2018 & 2024
Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 5: UK: Total Number of Diabetes Patients (in 000), 2011-2018
Figure 6: UK: Total Number of Diabetes Patients Forecast (in 000), 2019-2024
Figure 7: UK (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2011-2018
Figure 8: UK (Type1 & Type2): Total Number of Diabetes Patients Forecast (in 000), 2019-2024
Figure 9: UK (Urban & Rural): Total Number of Diabetes Patients (in 000), 2011-2018
Figure 10: UK (Urban & Rural): Total Number of Diabetes Patients Forecast (in 000), 2019-2024
Figure 11: UK (Male & Female): Total Number of Diabetes Patients (in 000), 2011-2018
Figure 12: UK (Male & Female): Total Number of Diabetes Patients Forecast (in 000), 2019-2024
Figure 13: UK: Total Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79, in 000), 2011-2018
Figure 14: UK: Total Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79, in 000), 2019-2024
Figure 15: UK: Diabetes Drug Industry Overview
Figure 16: UK: Diabetes Drug Market: Sales Value (in Million US$), 2011-2018
Figure 17: UK: Diabetes Drug Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 18: UK: Diabetes Drug Market: SWOT Analysis
Figure 19: UK: Diabetes Drug Market: Value Chain Analysis
Figure 20: UK: Diabetes Drug Market: Porters Five Forces Analysis
Figure 21: UK: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2011-2018
Figure 22: UK: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2019-2024
Figure 23: UK: Oral Antidiabetics Market: Sales Value (in Million US$), 2011-2018
Figure 24: UK: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2011 & 2018
Figure 25: UK: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 26: UK: Oral Antidiabetics Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 27: UK: Insulin Market: Sales Value (in Million US$), 2011-2018
Figure 28: UK: Breakup of Insulin Market by Class (in %), 2011 & 2018
Figure 29: UK: Insulin Market: Sales Share of Key Players (in %)
Figure 30: UK: Insulin Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2018 & 2024
Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 5: UK: Total Number of Diabetes Patients (in 000), 2011-2018
Figure 6: UK: Total Number of Diabetes Patients Forecast (in 000), 2019-2024
Figure 7: UK (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2011-2018
Figure 8: UK (Type1 & Type2): Total Number of Diabetes Patients Forecast (in 000), 2019-2024
Figure 9: UK (Urban & Rural): Total Number of Diabetes Patients (in 000), 2011-2018
Figure 10: UK (Urban & Rural): Total Number of Diabetes Patients Forecast (in 000), 2019-2024
Figure 11: UK (Male & Female): Total Number of Diabetes Patients (in 000), 2011-2018
Figure 12: UK (Male & Female): Total Number of Diabetes Patients Forecast (in 000), 2019-2024
Figure 13: UK: Total Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79, in 000), 2011-2018
Figure 14: UK: Total Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79, in 000), 2019-2024
Figure 15: UK: Diabetes Drug Industry Overview
Figure 16: UK: Diabetes Drug Market: Sales Value (in Million US$), 2011-2018
Figure 17: UK: Diabetes Drug Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 18: UK: Diabetes Drug Market: SWOT Analysis
Figure 19: UK: Diabetes Drug Market: Value Chain Analysis
Figure 20: UK: Diabetes Drug Market: Porters Five Forces Analysis
Figure 21: UK: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2011-2018
Figure 22: UK: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2019-2024
Figure 23: UK: Oral Antidiabetics Market: Sales Value (in Million US$), 2011-2018
Figure 24: UK: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2011 & 2018
Figure 25: UK: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 26: UK: Oral Antidiabetics Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 27: UK: Insulin Market: Sales Value (in Million US$), 2011-2018
Figure 28: UK: Breakup of Insulin Market by Class (in %), 2011 & 2018
Figure 29: UK: Insulin Market: Sales Share of Key Players (in %)
Figure 30: UK: Insulin Market Forecast: Sales Value (in Million US$), 2019-2024
